Prestige Biopharma raises 453 billion won from Korean IPO

Retrieved on: 2021-02-08 14:03:45

Tags for this article:

Biosimilar

Biotechnology

Drugs

Prestige Biopharma

Click the tags to see associated articles and topics

Prestige Biopharma raises 453 billion won from Korean IPO. View article details on hiswai:

Excerpt

SINGAPORE-BASED biotech firm Prestige Biopharma has raised net proceeds of 453 billion won (S$539.9 million) from an initial public offering (IPO) ...

Article found on: www.businesstimes.com.sg

View Original Article